You have 9 free searches left this month | to do more

mivavotinib

Mivavotinib is a drug used to treat Non-GCB/ABC Diffuse Large B-Cell Lymphoma and With and Without MyD88 and/or CD79B Mutations. Mivavotinib is being actively studied in 1 study; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Calithera Biosciences, Inc
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • With and Without MyD88 and/or CD79B Mutations
  • Mivavotinib
  • (no location specified)
2022-04-01
Apr 1, 2022